Tasquinimod treatment alone or combined with cisplatin significantly reduced the recruitment of granulocytic MDSCs (Cd11b+/Ly6G+) to the tumor compared to vehicle control or cisplatin alone treatment groups (Fig. 4B). This evidence concerns the gene ITGAM and neoplasm.